0
Views
6
CrossRef citations to date
0
Altmetric
Carcinoma of the prostate

Long Term Results of Ultrasonically Guided Implantation of 125-I Seeds Combined with External Irradiation in Localized Prostatic Cancer

, &
Pages 109-115 | Published online: 30 Mar 2023

REFERENCES

  • Anderson LL. Spacing nomograph for interstitial implants of 125—I seeds. Med Phys 1976; 3: 48–51.
  • Barringer BS. Radium in the treatment of carcinoma of the bladder and prostate. JAMA 1917; 68: 1227–1235.
  • Baumgartner G, Callahan D, McKiel CF, Zickgraf E. New transurethral system for interstitial radiation of prostate cancer. J Surg Oncol 1988; 39: 241–250.
  • Boileau MA, Dowling RA, Gonzales M, Handel PH, Benson GS, Corriere JN. Interstitial gold and external beam irradiation for prostate cancer. J Urol 1988; 139: 985–988.
  • Bosch PC, Forbes KA, Prassvinichai S, Miller JB, Golji H, Martin DC. Preliminary observations on the results of combined temporary 192—Iridium implantation and external beam irradiation for carcinoma of the prostate. J Urol 1986; 135: 722–725.
  • Carey PO, Lippert MC, Constable WC, Jones D, Talton BM. Combined gold seed implantation and external radiotherapy for stage B2 or C prostate cancer. J Urol 1988; 139: 989–994.
  • Crusinberry RA, Kramolovsky EV, Loening SA. Percutaneous transperineal placement of gold 198 seeds for treatment of carcinoma of the prostate. The Prostate 1987; 11: 59–67.
  • DeLaney TF, Shipley WU, O'Leary MP, Biggs PJ, Prout GR. Preoperative irradiation, lymphadenectomy, and 125—Iodine implantation for patients with localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1986; 12: 1779–1785.
  • El-Mahdi AM, Kuban DA, Schellhammer PF. The treatment of choice for localized poorly differentiated adenocarcinoma of the prostate. Am J Clin Oncol 1985; 8: 477–480.
  • Flocks RH, Kerr HD, Elkins HB, Culp D. Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (AU198): A preliminary report. J Urol 1952; 68: 510–522.
  • Freiha FS, Bagshaw MA. Carcinoma of the prostate: Results of post-irradiation biopsy. Prostate 1984; 5: 19–25.
  • Gervasi LA, Mata J, Easley JD, Wilbanks JH, Scale-Hawkins C, Carlton CE, Scardino PT. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: 332–336.
  • Grayhack JT, Assimos DG. Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. The Prostate 1983; 4: 13–35.
  • Hald T, Rasmussen F. Extraperitoneal pelvioscopy: A new aid in staging of lower urinary tract tumors. A preliminary report. J Urol 1980; 125: 245–248.
  • Hall EJ. Biological basis of brachytherapy. In: Hilaris BS, Nori D, eds. Brachytherapy Update: New York: Memorial Sloan—Kettering Cancer Center, 1986; 11–23.
  • Hastak SM, Gammelgaard J, Holm HH. Ultrasonically guided transperineal biopsy in the diagnosis of prostatic carcinoma. J Urol 1982; 128: 69–71.
  • Herr HW. Iodine—125 implantation in the management of localized prostatic carcinoma. Urol Clin North America 1980; 7: 605–613.
  • Holm HH, Juul N, Pedersen JF, Hansen H, Strøyer I. Transperineal 125—iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 1983; 130: 283–286.
  • Holm HH, Torp—Pedersen S, Myschetzky P. Transperineal seed-implantation guided by biplanar transrectal ultrasound. Urology 1990; 36: 249–252.
  • Iversen P. DAPROCA — Danish Prostatic Cancer Group. Acta Oncol, suppl. In press
  • Iversen P, Torp—Pedersen ST, Holm HH. Prostate cancer: Interstitial radiotherapy. In: Prostatic Ultrasonography. Ed. Resnick MI. Philadelphia. Pennsylvania: B.C. Decker Inc. 1990. 113–121.
  • Johansson J—E, Adami H—O, Andersson S—O. Bergström R, Krusemo UB. Kraaz W. Natural history of localized prostatic cancer. A population—based study in 223 untreated patients, Lancet 1989; 1: 799–803.
  • Jordan GH, Lynch DF, Warden SS, McCraw JD, Hoffman GC, Schellhammer PF. Major rectal complications following interstitial implantation of 125—Iodine for carcinoma of the prostate. J Urol 1985; 134: 1212–1214.
  • Kuban DA, El—Mahdi AM, Schellhammer PF. 1–125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer 1989; 63: 2415–2420.
  • Kumar PP, Good RR, Bartone FF, Jones EO, Lynch G. Transperineal 125—Iodine endocurie therapy of prostate cancer. Am J Clin Oncol 1988; 11: 479–489.
  • Lee F, Torp—Pedersen S, Meiselman L, Siders DB, Littrup P, Dorr RP, Pauli FJ. Transrectal ultrasound in the diagnosis and staging of local disease after 125—I seed implantation for prostate cancer. Int J Rad Oncol Biol Phys 1988; 15: 1453–1459.
  • Marchese MJ, Hall EJ, Hilaris BS. Encapsulated iodine—125 in radiation oncology: I. Study of the relative biological effectiveness (RBE) using low dose rate irradiation of mammalian cell cultures. Am J Clin Oncol 1984; 7: 607–611.
  • Morton JD, Peschell RE. Iodine—125 implants versus external beam therapy for stages A2. B, and C prostate cancer. Int J Rad Oncol Biol Phys 1988; 14: 1153–1157.
  • Scardino PT, Frankel JM, Wheeler TM, Meacham RB, Hoffman GS. Wilbanks JH, Easley J, Carlton CE. The prognostic significance of post—irradiation results in patients with prostatic cancer. JUrol 1986; 135: 510–516.
  • Schellhammer PF, El—Mahdi AM, Lagada LE, Schultheiss T. 125-Iodine implantation for carcinoma of the prostate. 5—year survival free of disease and incidence of local failure. J Urol 1985; 134: 1140–1145.
  • Schellhammer PF, El—Mahdi AM, Higgins EM, Schultheiss TE, Lagada LE, Babb TJ. Prostate biopsy after definitive treatment by interstitial 125-Iodine implant or external beam radiation therapy. J Urol 1987; 137: 897–901.
  • Shanberg AM, Tansey LA, Syed N, Puthawala A. Staging pelvic node dissection, temporary, transperineal iridium—192 implant and external irradiation in the treatment of prostatic carcinoma (meeting abstract). J Urol 1986; 135 (4, part 2): 246A.
  • Whitmore WF, Hilaris B, Batata M, Sogani P, Herr H, Morse M. Interstitial radiation: Short—term palliation or curative therapy. Urology 1985; 25 (suppl 2): 24–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.